Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Based on a ~ 8.5% annual event rate in the placebo arm, this would require about 3508 participants to be enrolled
I had a great mentor early on, he always talked about all the research that were going to ignore
Step 2: Reauthorization for Wegovy UnitedHealthcare may approve reauthorization and cover Wegovy for an additional 12 months after initial authorization if you meet two conditions: You must have lost at least 5% of your body weight during your first four months of taking Wegovy
General eligibility typically requires age 18 or older, BMI 30 or higher (27 or higher with a comorbidity), and no current GLP-1 medication use
Class-wide concerns: Cancer risk (GH/IGF-1 promote cell proliferation), glucose metabolism effects, fluid retention, joint/connective tissue effects
Glucagon-like peptide-1 agonists (GLP-1RA, GLP-1DAs, incretin mimetics, or GLP-1 analogs) represent a category of therapeutics used in the treatment of type 2 diabetes mellitus (T2DM) and obesity
